Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2026-01-30

Amgen gives up on its once-prized eczema drug

BioPharma Dive 2026-01-30

AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC

BioPharma Dive 2026-01-30

Politicization runs deeper than ever at FDA, risking long-term impacts

BioPharma Dive 2026-01-29

The biopharma industry outlook on 2026: Optimism and tension

BioPharma Dive 2026-01-29

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’

BioPharma Dive 2026-01-29

AstraZeneca strengthens China ties with planned $15B investment

BioPharma Dive 2026-01-29

Tenpoint wins FDA nod for combination presbyopia eye drop

BioPharma Dive 2026-01-28

Lilly bets on Seamless, delving further into genetic medicine for hearing loss

BioPharma Dive 2026-01-28

Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts

BioPharma Dive 2026-01-28

Halozyme buys a biotech startup; Cytokinetics launches heart drug

BioPharma Dive 2026-01-28

Regenxbio gene therapy trials suspended by FDA over safety worries

BioPharma Dive 2026-01-27

FDA lifts hold on an Intellia CRISPR drug trial

BioPharma Dive 2026-01-27

Roche, trailing in obesity, showcases new data for GLP-1 shot

BioPharma Dive 2026-01-27

An immune drug developer raises $50M to finance its eczema drug testing

BioPharma Dive 2026-01-26

China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

BioPharma Dive 2026-01-26

Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time

BioPharma Dive 2026-01-26

Biotech investor Cormorant secures $150M for another SPAC deal

BioPharma Dive 2026-01-26

Express Scripts considering settlement in FTC insulin price lawsuit

BioPharma Dive 2026-01-26

The formula for biotech success in 2026: Confidence, resilience and funding

BioPharma Dive 2026-01-26

From detection to prevention: How sponsored testing can transform patient outcomes

-195 / 9